T/CACM 1275-2019 Active Group standards

T/CACM 1275-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Systemic Scleroderma (Scleroderma)

T/CACM 1275-2019 Chinese Internal Medicine Clinical Guidelines for the Diagnosis and Treatment of Systemic Scleroderma (Scleroderma)

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CACM 1275-2019
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine
ICS Name: Comprehensive Pharmaceutical Science
Publish Date: 2019-01-30
Implement Date: 2020-01-01

Scope

Main technical content: This guide proposes the diagnosis, differentiation and treatment, other therapies, prevention and care advice for scleroderma. This guide is applicable to the diagnosis and prevention of scleroderma in people over the age of 18. This guide is suitable for clinicians in related fields such as traditional Chinese medicine, rheumatology and immunology, and dermatology.

Development Information

Related Standards

Contact Us